We are live on ! Find out more
OGEN icon

Oragenics
OGEN

26 hedge funds and large institutions have $4.96M invested in Oragenics in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

35% more capital inflows, than outflows

Capital inflows: $815K | Capital outflows: $605K

8% more funds holding

Funds holding: 24 → 26 (+2)

0.31% more ownership

Funds ownership: 9.25% → 9.56% (+0.31%)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

Holders
26
Holders Change
+2
Holders Change %
+8.33%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Sara-Bay Financial
Sara-Bay Financial
Florida
+$563K
2
GSA Capital Partners
GSA Capital Partners
United Kingdom
+$139K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$39.5K
4
Two Sigma Securities
Two Sigma Securities
New York
+$38.4K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$18.2K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$492K
2
Citadel Advisors
Citadel Advisors
Florida
-$45.5K
3
Virtu Financial
Virtu Financial
New York
-$39.5K
4
Jane Street
Jane Street
New York
-$12.1K
5
HRT Financial
HRT Financial
New York
-$10K

OGEN Hedge Fund Activity: Q4 2021 in Review

26 of the 6,521 institutional investors tracked by Wall St. Rank reported a position in Oragenics (OGEN) for Q4 2021, worth a combined $4.96M — down 27% from $6.82M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new OGEN positions and 1 closed out — a net gain of 2 holders — while 6 added to existing stakes and 6 trimmed.

The largest buyer was Sara-Bay Financial, adding an estimated $563K. The largest seller was Renaissance Technologies, cutting an estimated $492K.

  • 26 institutional investors held Oragenics (OGEN) as of Q4 2021, up from 24 in Q3 2021.
  • Funds reported $4.96M of Oragenics stock for Q4 2021, down 27% quarter-over-quarter.
  • 3 funds opened new Oragenics positions in Q4 2021 and 1 closed out, a net change of +2 holders.
  • The largest Oragenics buyer in Q4 2021 was Sara-Bay Financial, an estimated $563K added.
  • The largest Oragenics seller in Q4 2021 was Renaissance Technologies, an estimated $492K sold.

Based on aggregated 13F filings for Q4 2021.